, and far longer than the courses of therapies used in unsuccessful clinical trials of experimental agents, said John A. Kellum, M.D., professor, department of critical care medicine, University of Pittsburgh School of Medicine. We also found that the difference between the inflammatory response in a patient with a good outcome and a patient with a bad outcome is only a matter of degree.
The Pitt researchers say that in light of their results, treatments that completely abolish a specific component of the inflammatory response would be ineffective, and could be dangerous, since the inflammatory response is needed to address the underlying infection. Instead, they believe that therapies that address the chronic inflammatory response after sepsis and those that act more broadly on multiple components may yield better results.
No one really knows why some people develop sepsis following an infection, said Scott Somers, Ph.D., who oversees sepsis grants at the National Institute of General Medical Sciences, which partially funded the work. This large study gives us a much clearer picture of sepsisand shows us that its even more complicated than we thought.
The researchers plan to release several other reports from the GenIMS study in the coming months, which they hope will provide more clues to the condition.
'/>"/>
Page: 1 2 3 Related biology news :1.
Bioartificial kidney under study at MCG2.
Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down3.
W.M. Keck Foundation funds study of friendly microbes4.
Yellowstone microbes fueled by hydrogen, according to U. of Colorado study5.
Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs6.
UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims7.
Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible8.
Study Links Ebola Outbreaks To Animal Carcasses9.
Genome-wide mouse study yields link to human leukemia10.
Breakthrough Microarray-based Technology for the Study of Cancer11.
NYU Study Reveals How Brains Immune System Fights Viral Encephalitis